IPA EV/EBITDA
-1.53
+0.08+4.97%
Thu, 23 Jan 2025 00:59:56 GMT
Summary:
As of January 23, 2025, IPA EV/EBITDA is -1.53, with a rise of +0.08 (+4.97%) during the most recent trading day. Over the past year, it has increased by +5.07 (+76.82%). IPA EV/EBITDA is now -100.64% below its all-time high of 240.79.IPA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPA EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +5.0% |
| 1 m1 month | -24.4% |
| 3 m3 months | -14.2% |
| 6 m6 months | +14.5% |
| ytdytd | -22.4% |
| 1 y1 year | +76.8% |
| 5 y5 years | +88.0% |
IPA EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.21 | -26.4% | -1.61 | +5.0% |
| 3 m | 3-month | -1.08 | -41.7% | -1.64 | +6.7% |
| 6 m | 6-month | -1.08 | -41.7% | -2.04 | +25.0% |
| 1 y | 1-year | -1.08 | -41.7% | -9.57 | +84.0% |
| 3 y | 3-year | -1.08 | -41.7% | -13.12 | +88.3% |
| 5 y | 5-year | 240.79 | -100.6% | -715.32 | +99.8% |
| alltime | all time | 240.79 | -100.6% | -715.32 | +99.8% |
ImmunoPrecise Antibodies EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.53(+22.4%) |
| 2024 | -1.25(-79.8%) |
| 2023 | -6.20(-21.3%) |
| 2022 | -7.88(-26.0%) |
| 2021 | -10.65(-107.5%) |
| 2020 | 142.35(-1363.1%) |
| 2019 | -11.27(+16.4%) |
| 2018 | -9.68(+166.7%) |
| 2017 | -3.63(-153.5%) |
| 2016 | 6.78(-347.4%) |
| 2015 | -2.74(-35.2%) |
| 2014 | -4.23(-321.5%) |
| Date | Value |
|---|---|
| 2013 | 1.91(-190.1%) |
| 2012 | -2.12(-18.5%) |
| 2011 | -2.60(+504.7%) |
| 2010 | -0.43(-85.9%) |
| 2009 | -3.04(+121.9%) |
| 2008 | -1.37(-86.2%) |
| 2007 | -9.96(-56.9%) |
| 2006 | -23.11(-11.0%) |
| 2005 | -25.98(-22.5%) |
| 2004 | -33.53(-31.2%) |
| 2003 | -48.75(+268.2%) |
| 2002 | -13.24 |
FAQ
- What is ImmunoPrecise Antibodies EV/EBITDA?
- What is the all time high EV/EBITDA for ImmunoPrecise Antibodies?
- What is IPA EV/EBITDA year-to-date change?
- What is ImmunoPrecise Antibodies EV/EBITDA year-on-year change?
What is ImmunoPrecise Antibodies EV/EBITDA?
The current EV/EBITDA of IPA is -1.53
What is the all time high EV/EBITDA for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high EV/EBITDA is 240.79
What is IPA EV/EBITDA year-to-date change?
ImmunoPrecise Antibodies EV/EBITDA has changed by -0.28 (-22.40%) since the beginning of the year
What is ImmunoPrecise Antibodies EV/EBITDA year-on-year change?
Over the past year, IPA EV/EBITDA has changed by +5.07 (+76.82%)